• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

接受或未接受激素治疗的转移性前列腺癌患者的生活质量比较。

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy.

作者信息

Herr H W, Kornblith A B, Ofman U

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

出版信息

Cancer. 1993 Feb 1;71(3 Suppl):1143-50. doi: 10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i.

DOI:10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i
PMID:8428337
Abstract

BACKGROUND AND METHODS

The quality of life in patients who elected to receive hormonal therapy for newly diagnosed asymptomatic metastatic prostate cancer was compared with a comparable group of patients who chose to defer immediate intervention.

RESULTS AND CONCLUSIONS

The premise that active therapy, despite its side effects, would improve or maintain the psychosocial quality of life was not substantiated, and the no-therapy group had better physical and sexual functioning.

摘要

背景与方法

将选择接受激素治疗的新诊断无症状转移性前列腺癌患者的生活质量，与选择推迟立即干预的一组类似患者进行比较。

结果与结论

积极治疗尽管有副作用，但会改善或维持心理社会生活质量这一前提未得到证实，未治疗组的身体和性功能更好。

相似文献

1
A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy.接受或未接受激素治疗的转移性前列腺癌患者的生活质量比较。
Cancer. 1993 Feb 1;71(3 Suppl):1143-50. doi: 10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i.
2
[A comparison of the quality of life of prostatic cancer patients under slow releasing LH-RH analogue (TAP-144SR Depot) treatment or synthetic estrogen treatment].[缓释促黄体生成素释放激素类似物（TAP-144SR长效注射剂）治疗或合成雌激素治疗下前列腺癌患者生活质量的比较]
Hinyokika Kiyo. 1991 Sep;37(9):1017-22.
3
Population based study of hormonal therapy and survival in men with metastatic prostate cancer.基于人群的转移性前列腺癌男性激素治疗与生存情况研究。
J Urol. 2007 Feb;177(2):535-9. doi: 10.1016/j.juro.2006.09.049.
4
Prognostic significance of prostate-specific antigen levels two months after hormonal manipulation of metastatic prostate cancer.转移性前列腺癌激素治疗两个月后前列腺特异性抗原水平的预后意义
Eur Urol. 1997;32(1):58-63.
5
Quality of life in patients with prostatic carcinoma: a review and results of a study in N+ disease. Prostate-specific antigen as predictor of quality of life.
Urol Res. 1997;25 Suppl 2:S79-88. doi: 10.1007/BF00941993.
6
Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.间歇性雄激素剥夺疗法治疗局部晚期和转移性前列腺癌：来自南欧泌尿肿瘤学组的一项随机3期研究结果
Eur Urol. 2009 Jun;55(6):1269-77. doi: 10.1016/j.eururo.2009.02.016. Epub 2009 Feb 21.
7
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).雄激素剥夺疗法作为局限性前列腺癌的主要治疗方法：来自前列腺癌战略泌尿学研究计划（CaPSURE）的数据。
Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799.
8
Quality of Life, Psychological Functioning, and Treatment Satisfaction of Men Who Have Undergone Penile Prosthesis Surgery Following Robot-Assisted Radical Prostatectomy.机器人辅助根治性前列腺切除术后接受阴茎假体手术的男性的生活质量、心理功能和治疗满意度。
J Sex Med. 2017 Dec;14(12):1612-1620. doi: 10.1016/j.jsxm.2017.10.001. Epub 2017 Oct 27.
9
Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.随机分配接受激素药物治疗或密切监测的前列腺癌男性的应对方式及与健康相关的生活质量
Psychooncology. 2002 Sep-Oct;11(5):401-14. doi: 10.1002/pon.599.
10
Hormonal management of advanced adenocarcinoma of the prostate.晚期前列腺腺癌的激素治疗
Henry Ford Hosp Med J. 1989;37(1):16-8.

引用本文的文献

1
Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.晚期激素敏感性前列腺癌的早期与延迟标准雄激素抑制治疗
Cochrane Database Syst Rev. 2019 Jun 11;6(6):CD003506. doi: 10.1002/14651858.CD003506.pub2.
2
Comparing PROMIS computer-adaptive tests to the Brief Symptom Inventory in patients with prostate cancer.比较前列腺癌患者中患者报告结果测量信息系统（PROMIS）计算机自适应测试与简明症状量表。
Qual Life Res. 2014 Sep;23(7):2031-5. doi: 10.1007/s11136-014-0647-2. Epub 2014 Feb 16.
3
Quality of life issues in men undergoing androgen deprivation therapy: a review.
男性接受雄激素剥夺治疗的生活质量问题：综述。
Asian J Androl. 2012 Mar;14(2):226-31. doi: 10.1038/aja.2011.108. Epub 2012 Jan 9.
4
Hormone use after radiotherapy failure: a survey of Canadian uro-oncology specialists.放疗失败后的激素使用：加拿大泌尿肿瘤专家的一项调查
Can Urol Assoc J. 2009 Dec;3(6):460-4. doi: 10.5489/cuaj.1175.
5
Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer.接受间歇性联合雄激素阻断治疗的非转移性前列腺癌男性患者的认知和情绪变化
Psychooncology. 2009 Mar;18(3):237-47. doi: 10.1002/pon.1401.
6
Psychological adjustment of men with prostate cancer: a review of the literature.前列腺癌男性的心理调适：文献回顾。
Biopsychosoc Med. 2007 Jan 10;1:2. doi: 10.1186/1751-0759-1-2.
7
Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer.生活质量作为转移性激素难治性前列腺癌患者发病和死亡的潜在预测指标。
Qual Life Res. 2006 Oct;15(8):1297-306. doi: 10.1007/s11136-006-0003-2. Epub 2006 Aug 10.
8
Prostate cancer in the elderly.老年前列腺癌
Int Urol Nephrol. 2005;37(4):797-806. doi: 10.1007/s11255-005-0402-2.
9
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
Curr Oncol Rep. 2004 Jul;6(4):277-84. doi: 10.1007/s11912-004-0036-z.
10
Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.前列腺癌患者与其临床医生之间关于效用和属性重要性的共识。
Health Expect. 2004 Jun;7(2):115-25. doi: 10.1111/j.1369-7625.2004.00267.x.